Whole-Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia

被引：0
|
作者：
Ravindra, N. [1 ]
Hourigan, C. [1 ]
Dillon, L. [2 ]
Lack, J. [3 ]
Dalgard, C. [4 ]
vanCollenburg, E. [5 ]
Corner, A. [5 ]
Beppu, L. [6 ]
Erba, H. [7 ]
Othus, M. [8 ]
Radich, J. [6 ,9 ]
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NHLBI, Lab Myeloid Malignancies, Bldg 10, Bethesda, MD 20892 USA
[3] NIH, Integrated Data Sci Sect, Bldg 10, Bethesda, MD 20892 USA
[4] Uniformed Serv Univ Hlth Sci, Amer Genome Ctr, Bethesda, MD 20814 USA
[5] Digital Biol Grp, Biorad Labs, Pleasanton, CA USA
[6] Fred Hutchinson Canc Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[7] Duke Univ, Sch Med, Durham, NC USA
[8] Fred Hutchinson Canc Ctr, Publ Hlth Sci Div, Seattle, WA USA
[9] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
H020
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Measurable residual disease testing for personalized treatment of acute myeloid leukemia
    Ehinger, Mats
    Pettersson, Louise
    APMIS, 2019, 127 (05) : 337 - 351
  • [2] Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study
    Arthur, Cecilia
    Rezayee, Fatemah
    Mogensen, Nina
    Saft, Leonie
    Rosenquist, Richard
    Nordenskjold, Magnus
    Harila-Saari, Arja
    Tham, Emma
    Barbany, Gisela
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Tracking Measurable Residual Disease in Acute Myeloid Leukemia with Error Corrected Sequencing
    D'Angelo, J.
    Huang, Y.
    Kebede, Y.
    Miick, S.
    Salva, N.
    Troung, C.
    Turner, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S38 - S38
  • [4] Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia
    Yoest, Jennifer M.
    Shirai, Cara Lunn
    Duncavage, Eric J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [5] Whole-Genome Sequencing and Acute Promyelocytic Leukemia
    Lo-Coco, Francesco
    Sanz, Miguel A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (06): : 610 - 610
  • [6] Reference materials for the development of assays for the detection of measurable residual disease in acute myeloid leukemia
    Elango, Rajula
    Butler, Matthew G.
    Dahal, Ojaswee
    Ramprakash, Jayanthi
    Merriam, David
    Konigshofer, Yves
    Garlick, Russell K.
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
    Dillon, Laura W.
    Higgins, Jake
    Nasif, Hassan
    Othus, Megan
    Beppu, Lan
    Smith, Thomas H.
    Schmidt, Elizabeth
    Valentine III, Charles C.
    Salk, Jesse J.
    Wood, Brent L.
    Erba, Harry P.
    Radich, Jerald P.
    Hourigan, Christopher S.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 401 - 410
  • [8] Evaluating measurable residual disease in acute myeloid leukemia
    Ravandi, Farhad
    Walter, Roland B.
    Freeman, Sylvie D.
    BLOOD ADVANCES, 2018, 2 (11) : 1356 - 1366
  • [9] Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
    Dillon, Laura W.
    Higgins, Jake
    Nasif, Hassan
    Othus, Megan
    Beppu, Lan
    Smith, Thomas H.
    Schmidt, Elizabeth
    Valentine III, Charles C.
    Salk, Jesse J.
    Wood, Brent L.
    Erba, Harry P.
    Radich, Jerald P.
    Hourigan, Christopher S.
    HAEMATOLOGICA, 2024, 109 (02) : 401 - 410
  • [10] Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
    Dillon, Laura W.
    Hayati, Sheida
    Roloff, Gregory W.
    Tunc, Ilker
    Pirooznia, Mehdi
    Mitrofanova, Antonina
    Hourigan, Christopher S.
    HAEMATOLOGICA, 2019, 104 (02) : 297 - 304
12345